EU hits 200-million-jab milestone

Credit: CC0 Public Domain

At least 200 million doses of COVID-19 vaccines have been given in the European Union as of Tuesday, according to AFP data tallying up official figures given by member states' health services.

The milestone indicates that the EU should be on track to meet its goal of fully vaccinating 70 percent of adults—meaning roughly 255 million people out of its total 448 million population—by late July.

As of 0830 GMT, at least 200 million doses have been administered in the EU, according to the AFP data.

At least 52.9 million people have been completely vaccinated, with two doses in the case of the vaccines from BioNTech/Pfizer, Moderna and AstraZeneca, or one dose for those inoculated with the single-shot Johnson & Johnson vaccine.

That figure amounts to 11.8 percent of the EU population.

The data showed that Malta was leading the EU table, with 32.5 percent of its small population fully vaccinated, while Bulgaria was trailing badly, with just 6.1 percent inoculated.

Of the big EU countries, Germany has 11.1 percent fully vaccinated, France has 13.5 percent, Italy has 14.6 percent and Spain has 15.4 percent.

Globally, the AFP data showed that 1.5 billion doses have been administered.

By way of comparison with other wealthy territories, Israel has 59 percent of its inoculated with two doses, while the United States has 35 percent fully vaccinated, and Britain has 30 percent done.

The European Commission, contacted by AFP, did not immediately respond with comment about the vaccination milestone.

It did however say that its export authorisation mechanism had, between January 30 and May 11, approved 941 export requests from producing COVID-19 vaccines in the EU and rejected one—a March shipment of 250,000 AstraZeneca doses meant for Australia.

The vaccines exports went to 45 countries and territories, it said, including the United States, Britain, Israel, India, Australia, Canada and Brazil.

© 2021 AFP

Citation: EU hits 200-million-jab milestone (2021, May 18) retrieved 13 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors